awmsg logo



etoricoxib (Arcoxia®)


Reference No. 981

Publication date:
01/11/2012


Appraisal information

etoricoxib (Arcoxia®) 30 mg film-coated tablet
etoricoxib (Arcoxia®) 60 mg film-coated tablet
etoricoxib (Arcoxia®) 90 mg film-coated tablet
etoricoxib (Arcoxia®) 120 mg film-coated tablet


Company: Merck Sharp & Dohme Ltd
BNF category: Musculoskeletal and joint diseases
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 25/10/2012

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, etoricoxib (Arcoxia®) cannot be endorsed for use within NHS Wales for the short-term treatment of moderate pain associated with dental surgery.
Statement of Advice (SOA)
Download